Target Product Profiles for Diagnostics The Cystic Fibrosis (CF) Antimicrobial Resistance (AMR) Syndicate recently launched their diagnostic target product profiles (TPPs) detailing key characteristics of new tests needed to detect and manage lung infections in CF. A...
CF AMR Syndicate: Lifting The Limits Of Cystic Fibrosis Antimicrobial Development Exploring the theme of ‘lifting the limits together’, this week (13-19 June) marks Cystic Fibrosis (CF) Week 2022. The event is a week-long opportunity to celebrate the courage and...
NBIC Core Partners to Advance New Treatments for Cystic Fibrosis Infections NBIC core partners, the Universities of Liverpool and Nottingham, are leading on a Strategic Research Centre as part of a new international collaboration to accelerate the development of much...
